{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:08:11Z","timestamp":1793653691966,"version":"4.5.1"},"reference-count":158,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec><jats:title>Objective:<\/jats:title><jats:p>To describe the pathophysiology associated with multiple organ dysfunction syndrome in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Sources:<\/jats:title><jats:p>Literature review, research data, and expert opinion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Selection:<\/jats:title><jats:p>Not applicable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Extraction:<\/jats:title><jats:p>Moderated by an experienced expert from the field, pathophysiologic processes associated with multiple organ dysfunction syndrome in children were described, discussed, and debated with a focus on identifying knowledge gaps and research priorities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Synthesis:<\/jats:title><jats:p>Summary of presentations and discussion supported and supplemented by relevant literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Experiment modeling suggests that persistent macrophage activation may be a pathophysiologic basis for multiple organ dysfunction syndrome. Children with multiple organ dysfunction syndrome have 1) reduced cytochrome P450 metabolism inversely proportional to inflammation; 2) increased circulating damage-associated molecular pattern molecules from injured tissues; 3) increased circulating pathogen-associated molecular pattern molecules from infection or endogenous microbiome; and 4) cytokine-driven epithelial, endothelial, mitochondrial, and immune cell dysfunction. Cytochrome P450s metabolize endogenous compounds and xenobiotics, many of which ameliorate inflammation, whereas damage-associated molecular pattern molecules and pathogen-associated molecular pattern molecules alone and together amplify the cytokine production leading to the inflammatory multiple organ dysfunction syndrome response. Genetic and environmental factors can impede inflammation resolution in children with a spectrum of multiple organ dysfunction syndrome pathobiology phenotypes. Thrombocytopenia-associated multiple organ dysfunction syndrome patients have extensive endothelial activation and thrombotic microangiopathy with associated oligogenic deficiencies in inhibitory complement and a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13. Sequential multiple organ dysfunction syndrome patients have soluble Fas ligand-Fas\u2013mediated hepatic failure with associated oligogenic deficiencies in perforin and granzyme signaling. Immunoparalysis-associated multiple organ dysfunction syndrome patients have impaired ability to resolve infection and have associated environmental causes of lymphocyte apoptosis. These inflammation phenotypes can lead to macrophage activation syndrome. Resolution of multiple organ dysfunction syndrome requires elimination of the source of inflammation. Full recovery of organ functions is noted 6\u201318 weeks later when epithelial, endothelial, mitochondrial, and immune cell regeneration and reprogramming is completed.<\/jats:p><\/jats:sec>","DOI":"10.1097\/pcc.0000000000001052","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T12:28:18Z","timestamp":1488371298000},"page":"S32-S45","source":"Crossref","is-referenced-by-count":77,"title":["Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome"],"prefix":"10.1097","volume":"18","author":[{"given":"Joseph A.","family":"Carcillo","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine and Pediatrics, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Podd","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine and Pediatrics, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Aneja","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine and Pediatrics, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy T.","family":"Cornell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Shanley","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Doughty","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung C.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Texas Children\u2019s Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archsurg.1975.01360130011001","article-title":"Multiple, progressive, or sequential systems failure. A syndrome of the 1970s.","volume":"110","author":"Baue","year":"1975","journal-title":"Arch Surg"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0002-9610(85)80124-0","article-title":"Recovery from multiple organ failure.","volume":"149","author":"Baue","year":"1985","journal-title":"Am J Surg"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0039-6109(16)45433-2","article-title":"Nutrition and metabolism in sepsis and multisystem organ failure.","volume":"71","author":"Baue","year":"1991","journal-title":"Surg Clin North Am"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/archsurg.1992.01420120085016","article-title":"The horror autotoxicus and multiple-organ failure.","volume":"127","author":"Baue","year":"1992","journal-title":"Arch Surg"},{"key":"R5-20230823","first-page":"51","article-title":"MEGX (monoethylglycinexylidide): A novel in vivo test to measure early hepatic dysfunction after hypovolemic shock.","volume":"3","author":"Chandel","year":"1995","journal-title":"Shock"},{"issue":"Suppl 1","key":"R6-20230823","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00024382-199606001-00002","article-title":"MOF\/MODS, SIRS: An update.","volume":"6","author":"Baue","year":"1996","journal-title":"Shock"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archsurg.1989.01410120036008","article-title":"Development of a bacteria-independent model of the multiple organ failure syndrome.","volume":"124","author":"Steinberg","year":"1989","journal-title":"Arch Surg"},{"key":"R8-20230823","first-page":"57","article-title":"The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity.","volume":"102","author":"Carcillo","year":"1998","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10753-007-9049-8","article-title":"Etoposide attenuates zymosan-induced shock in mice.","volume":"31","author":"Remichkova","year":"2008","journal-title":"Inflammation"},{"key":"R10-20230823","first-page":"233","article-title":"The effect of VP 16-213 on NBT reduction in the normal polymorphonuclear neutrophil.","volume":"4","author":"Bender","year":"1980","journal-title":"Cancer Biochem Biophys"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3468(00)90207-0","article-title":"A comparison of neonatal and adult multiorgan failure in a rat model.","volume":"35","author":"Jackson","year":"2000","journal-title":"J Pediatr Surg"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jpedsurg.2004.11.042","article-title":"Altered chemokine response in an animal model of multiple organ dysfunction syndrome induced by zymosan.","volume":"40","author":"Thomas","year":"2005","journal-title":"J Pediatr Surg"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"L71","DOI":"10.1152\/ajplung.00054.2014","article-title":"NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome.","volume":"307","author":"Whitmore","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00003246-199801000-00032","article-title":"Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis.","volume":"26","author":"Doughty","year":"1998","journal-title":"Crit Care Med"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.109.4.1033","article-title":"Epidemiology of sepsis and multiple organ dysfunction syndrome in children.","volume":"109","author":"Proulx","year":"1996","journal-title":"Chest"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00134-003-1758-3","article-title":"Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure.","volume":"29","author":"Carcillo","year":"2003","journal-title":"Intensive Care Med"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/smim.1998.0143","article-title":"An innate sense of danger.","volume":"10","author":"Matzinger","year":"1998","journal-title":"Semin Immunol"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/00003246-199607000-00012","article-title":"Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure.","volume":"24","author":"Doughty","year":"1996","journal-title":"Crit Care Med"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1378\/chest.113.6.1625","article-title":"The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure.","volume":"113","author":"Doughty","year":"1998","journal-title":"Chest"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1097\/00003246-200007000-00070","article-title":"Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure.","volume":"28","author":"Whalen","year":"2000","journal-title":"Crit Care Med"},{"key":"R21-20230823","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3565(24)29677-4","article-title":"Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.","volume":"296","author":"Thomas","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00008480-200106000-00006","article-title":"Pediatric sepsis and multiple organ dysfunction syndrome.","volume":"13","author":"Despond","year":"2001","journal-title":"Curr Opin Pediatr"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0037-1612976","article-title":"The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.","volume":"87","author":"Green","year":"2002","journal-title":"Thromb Haemost"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.PCC.0000161075.97355.2E","article-title":"Extracellular hsp70 levels in children with septic shock.","volume":"6","author":"Wheeler","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00011-007-6108-4","article-title":"Extracellular heat shock protein 60 (Hsp60) levels in children with septic shock.","volume":"56","author":"Wheeler","year":"2007","journal-title":"Inflamm Res"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/shk.0b013e318123867b","article-title":"Admission angiopoietin levels in children with septic shock.","volume":"28","author":"Giuliano","year":"2007","journal-title":"Shock"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0749-0704(03)00013-7","article-title":"Pediatric septic shock and multiple organ failure.","volume":"19","author":"Carcillo","year":"2003","journal-title":"Crit Care Clin"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc5064","article-title":"Bench-to-bedside review: Thrombocytopenia-associated multiple organ failure\u2013a newly appreciated syndrome in the critically ill.","volume":"10","author":"Nguyen","year":"2006","journal-title":"Crit Care"},{"key":"R29-20230823","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.CCM.0000257468.75474.D4","article-title":"Understanding the role of von Willebrand factor and its cleaving protease ADAM TS13 in the pathophysiology of critical illness.","volume":"8","author":"Nguyen","year":"2007","journal-title":"Pediatr Crit Care Med"},{"key":"R30-20230823","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1097\/CCM.0b013e318186aa49","article-title":"Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.","volume":"36","author":"Nguyen","year":"2008","journal-title":"Crit Care Med"},{"key":"R31-20230823","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"R32-20230823","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/cc8992","article-title":"4G\/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: Prospective, observational, genetic study.","volume":"14","author":"Mad\u00e1ch","year":"2010","journal-title":"Crit Care"},{"key":"R33-20230823","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"R34-20230823","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1073\/pnas.172277399","article-title":"Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.","volume":"99","author":"Kokame","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-20230823","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood-2003-06-1796","article-title":"Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.","volume":"103","author":"Matsumoto","year":"2004","journal-title":"Blood"},{"key":"R36-20230823","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood-2003-04-1346","article-title":"Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13.","volume":"103","author":"Pimanda","year":"2004","journal-title":"Blood"},{"key":"R37-20230823","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood-2002-08-2399","article-title":"von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.","volume":"101","author":"Schneppenheim","year":"2003","journal-title":"Blood"},{"key":"R38-20230823","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood-2004-02-0715","article-title":"Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura.","volume":"104","author":"Uchida","year":"2004","journal-title":"Blood"},{"key":"R39-20230823","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation.","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R40-20230823","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R41-20230823","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis.","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"R42-20230823","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R43-20230823","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R44-20230823","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(11)61145-8","article-title":"Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: An observational study.","volume":"378","author":"Colic","year":"2011","journal-title":"Lancet"},{"key":"R45-20230823","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00467-011-1944-4","article-title":"Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.","volume":"26","author":"Kim","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R46-20230823","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: An analysis of the German STEC-HUS registry.","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R47-20230823","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS.","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"R48-20230823","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jca.20296","article-title":"Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange.","volume":"26","author":"Qu","year":"2011","journal-title":"J Clin Apher"},{"key":"R49-20230823","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1097\/PCC.0000000000000227","article-title":"Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network.","volume":"15","author":"Sevketoglu","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R50-20230823","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PCC.0000000000000372","article-title":"Therapeutic plasma exchange as a strategy to reverse multiple organ dysfunction syndrome in patients receiving extracorporeal life support.","volume":"16","author":"Nguyen","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R51-20230823","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2174\/157016112803520738","article-title":"Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease.","volume":"10","author":"Zhou","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"R52-20230823","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1160\/TH08-10-0677","article-title":"Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: A mechanism associated with sickle cell disease.","volume":"101","author":"Zhou","year":"2009","journal-title":"Thromb Haemost"},{"key":"R53-20230823","doi-asserted-by":"crossref","first-page":"e1000349","DOI":"10.1371\/journal.ppat.1000349","article-title":"Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.","volume":"5","author":"Larkin","year":"2009","journal-title":"PLoS Pathog"},{"key":"R54-20230823","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2015-08-663245","article-title":"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.","volume":"127","author":"Vinchi","year":"2016","journal-title":"Blood"},{"key":"R55-20230823","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2010-04-280479","article-title":"Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus).","volume":"116","author":"Feys","year":"2010","journal-title":"Blood"},{"key":"R56-20230823","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1160\/TH10-03-0153","article-title":"ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus deposition.","volume":"105","author":"Bockmeyer","year":"2011","journal-title":"Thromb Haemost"},{"key":"R57-20230823","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1203\/00006450-200212000-00018","article-title":"sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome.","volume":"52","author":"Doughty","year":"2002","journal-title":"Pediatr Res"},{"key":"R58-20230823","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"R59-20230823","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1302282","article-title":"Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.","volume":"192","author":"Johnson","year":"2014","journal-title":"J Immunol"},{"key":"R60-20230823","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/blood-2012-07-441139","article-title":"Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease.","volume":"121","author":"K\u00f6gl","year":"2013","journal-title":"Blood"},{"key":"R61-20230823","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","article-title":"Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.","volume":"10","author":"Castillo","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R62-20230823","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/PCC.0000000000000098","article-title":"Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome\/secondary hemophagocytic lymphohistiocytosis syndrome.","volume":"15","author":"Simon","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R63-20230823","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MOP.0000000000000352","article-title":"Inflammation and innate immune function in critical illness.","volume":"28","author":"Muszynski","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"R64-20230823","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOP.0000000000000357","article-title":"Adaptive immune function in critical illness.","volume":"28","author":"Doughty","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"R65-20230823","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.174.6.3765","article-title":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure.","volume":"174","author":"Felmet","year":"2005","journal-title":"J Immunol"},{"key":"R66-20230823","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","article-title":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome.","volume":"37","author":"Hall","year":"2011","journal-title":"Intensive Care Med"},{"key":"R67-20230823","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/pr.2013.121","article-title":"Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome\/sepsis patients.","volume":"74","author":"Halstead","year":"2013","journal-title":"Pediatr Res"},{"key":"R68-20230823","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","article-title":"Genetic defects in cytolysis in macrophage activation syndrome.","volume":"16","author":"Zhang","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"R69-20230823","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc11256","article-title":"Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: What is the treatment?","volume":"16","author":"Demirkol","year":"2012","journal-title":"Crit Care"},{"key":"R70-20230823","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PCC.0000000000000078","article-title":"Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction\/macrophage activating syndrome in critically ill children.","volume":"15","author":"Rajasekaran","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R71-20230823","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1182\/blood-2013-02-485623","article-title":"Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.","volume":"121","author":"Teachey","year":"2013","journal-title":"Blood"},{"key":"R72-20230823","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome.","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"R73-20230823","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling.","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R74-20230823","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.4049\/jimmunol.177.6.3507","article-title":"Nucleotide-binding oligomerization domain-like receptors: Intracellular pattern recognition molecules for pathogen detection and host defense.","volume":"177","author":"Franchi","year":"2006","journal-title":"J Immunol"},{"key":"R75-20230823","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/path.2284","article-title":"Macrophage activation by endogenous danger signals.","volume":"214","author":"Zhang","year":"2008","journal-title":"J Pathol"},{"issue":"10 Pt 1","key":"R76-20230823","first-page":"et al","article-title":"HMGB1 as a late mediator of lethal systemic inflammation.","volume":"164","author":"Wang","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R77-20230823","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: All we need to know about danger.","volume":"81","author":"Bianchi","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R78-20230823","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00441-010-1033-1","article-title":"High-mobility group box 1 (HMGB1) as a master regulator of innate immunity.","volume":"343","author":"Castiglioni","year":"2011","journal-title":"Cell Tissue Res"},{"key":"R79-20230823","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0952-7915(00)00191-6","article-title":"Danger signals: SOS to the immune system.","volume":"13","author":"Gallucci","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"R80-20230823","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice.","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"R81-20230823","first-page":"A264","article-title":"High mobility group box 1(HMGB1) clearance with plasma exchange in pediatric patients with sepsis and thrombocytopenia-associated with multiple organ failure.","volume":"35","author":"Aneja","year":"2007","journal-title":"Crit Care Med"},{"key":"R82-20230823","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.CCM.0000155991.88802.4D","article-title":"Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.","volume":"33","author":"Sund\u00e9n-Cullberg","year":"2005","journal-title":"Crit Care Med"},{"key":"R83-20230823","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1097\/01.CCM.0000287588.69000.97","article-title":"Systemic and local high mobility group box 1 concentrations during severe infection.","volume":"35","author":"van Zoelen","year":"2007","journal-title":"Crit Care Med"},{"key":"R84-20230823","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00134-008-1032-9","article-title":"HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis.","volume":"34","author":"Karlsson","year":"2008","journal-title":"Intensive Care Med"},{"key":"R85-20230823","article-title":"Pediatric multiple organ dysfunction syndrome: Promising therapies.","volume":"18(Suppl)","author":"Doctor","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R86-20230823","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00216-011-4764-2","article-title":"Mitochondrial ROS production under cellular stress: Comparison of different detection methods.","volume":"400","author":"Kuznetsov","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"R87-20230823","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","article-title":"Association between mitochondrial dysfunction and severity and outcome of septic shock.","volume":"360","author":"Brealey","year":"2002","journal-title":"Lancet"},{"key":"R88-20230823","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0749-0704(03)00071-X","article-title":"Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?","volume":"18","author":"Fink","year":"2002","journal-title":"Crit Care Clin"},{"key":"R89-20230823","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/cc1824","article-title":"Bench-to-bedside review: Cytopathic hypoxia.","volume":"6","author":"Fink","year":"2002","journal-title":"Crit Care"},{"key":"R90-20230823","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2110-5820-1-41","article-title":"Mitochondrial dysfunction and biogenesis: Do ICU patients die from mitochondrial failure?","volume":"1","author":"Kozlov","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R91-20230823","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1113\/jphysiol.2011.212712","article-title":"Mitochondria: Isolation, structure and function.","volume":"589","author":"Picard","year":"2011","journal-title":"J Physiol"},{"key":"R92-20230823","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1097\/01.CCM.0000278049.48333.78","article-title":"Mitochondrial function in sepsis: Acute phase versus multiple organ failure.","volume":"35","author":"Singer","year":"2007","journal-title":"Crit Care Med"},{"key":"R93-20230823","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.mito.2004.07.023","article-title":"Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome.","volume":"4","author":"Crouser","year":"2004","journal-title":"Mitochondrion"},{"key":"R94-20230823","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/TA.0b013e3182988b1f","article-title":"Hemorrhagic shock and resuscitation are associated with peripheral blood mononuclear cell mitochondrial dysfunction and immunosuppression.","volume":"75","author":"Villarroel","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R95-20230823","first-page":"2702","article-title":"Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis.","volume":"35","author":"Belikova","year":"2007","journal-title":"Crit Care Med"},{"key":"R96-20230823","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1097\/PCC.0000000000000277","article-title":"Mitochondrial dysfunction in peripheral blood mononuclear cells in pediatric septic shock.","volume":"16","author":"Weiss","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R97-20230823","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/s13054-014-0623-9","article-title":"Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shock.","volume":"18","author":"Weiss","year":"2014","journal-title":"Crit Care"},{"key":"R98-20230823","doi-asserted-by":"crossref","first-page":"195ra95","DOI":"10.1126\/scitranslmed.3005893","article-title":"An integrated clinico-metabolomic model improves prediction of death in sepsis.","volume":"5","author":"Langley","year":"2013","journal-title":"Sci Transl Med"},{"key":"R99-20230823","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/ars.2014.6200","article-title":"Regulation of mitochondrial biogenesis and its intersection with inflammatory responses.","volume":"22","author":"Cherry","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"R100-20230823","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ni0311-199","article-title":"Mitochondrial control of the NLRP3 inflammasome.","volume":"12","author":"Kepp","year":"2011","journal-title":"Nat Immunol"},{"key":"R101-20230823","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury.","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"R102-20230823","doi-asserted-by":"crossref","first-page":"e1001577","DOI":"10.1371\/journal.pmed.1001577","article-title":"Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: Derivation and validation.","volume":"10","author":"Nakahira","year":"2013","journal-title":"PLoS Med"},{"key":"R103-20230823","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.mito.2012.10.011","article-title":"Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?","volume":"13","author":"Malik","year":"2013","journal-title":"Mitochondrion"},{"key":"R104-20230823","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.shk.0000235089.30550.2d","article-title":"Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis.","volume":"28","author":"Levy","year":"2007","journal-title":"Shock"},{"key":"R105-20230823","doi-asserted-by":"crossref","first-page":"L962","DOI":"10.1152\/ajplung.00073.2014","article-title":"Mitochondria in lung biology and pathology: More than just a powerhouse.","volume":"306","author":"Schumacker","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R106-20230823","first-page":"127","article-title":"Immune modulation in sepsis.","volume":"4","author":"Hall","year":"2009","journal-title":"J Pediatr Infect Dis"},{"key":"R107-20230823","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-125-8-199610150-00009","article-title":"Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)","volume":"125","author":"Bone","year":"1996","journal-title":"Ann Intern Med"},{"key":"R108-20230823","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/infdis\/jis721","article-title":"Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.","volume":"207","author":"Mella","year":"2013","journal-title":"J Infect Dis"},{"key":"R109-20230823","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/CCM.0b013e318267633c","article-title":"Innate immune function and mortality in critically ill children with influenza: A multicenter study.","volume":"41","author":"Hall","year":"2013","journal-title":"Crit Care Med"},{"key":"R110-20230823","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/SHK.0000000000000217","article-title":"Innate immune function predicts the development of nosocomial infection in critically injured children.","volume":"42","author":"Muszynski","year":"2014","journal-title":"Shock"},{"key":"R111-20230823","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1097\/01.CCM.0000240243.28129.36","article-title":"Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery.","volume":"34","author":"Allen","year":"2006","journal-title":"Crit Care Med"},{"key":"R112-20230823","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jtcvs.2011.09.011","article-title":"Clinical implications and molecular mechanisms of immunoparalysis after cardiopulmonary bypass.","volume":"143","author":"Cornell","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R113-20230823","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","article-title":"Developing a clinically feasible personalized medicine approach to pediatric septic shock.","volume":"191","author":"Wong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R114-20230823","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.20111354","article-title":"A genomic storm in critically injured humans.","volume":"208","author":"Xiao","year":"2011","journal-title":"J Exp Med"},{"key":"R115-20230823","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/trf.12896","article-title":"Red blood cell transfusion and immune function in critically ill children: A prospective observational study.","volume":"55","author":"Muszynski","year":"2015","journal-title":"Transfusion"},{"key":"R116-20230823","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/S0140-6736(05)63910-4","article-title":"Genetic influence on cytokine production in meningococcal disease.","volume":"349","author":"Westendorp","year":"1997","journal-title":"Lancet"},{"key":"R117-20230823","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial.","volume":"180","author":"Meisel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 4","key":"R118-20230823","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1007\/BF01743727","article-title":"Monocyte deactivation\u2013rationale for a new therapeutic strategy in sepsis.","volume":"22","author":"Volk","year":"1996","journal-title":"Intensive Care Med"},{"key":"R119-20230823","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1373\/clinchem.2005.052639","article-title":"Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: A multicenter standardized study.","volume":"51","author":"D\u00f6cke","year":"2005","journal-title":"Clin Chem"},{"key":"R120-20230823","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00134-014-3352-2","article-title":"Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: A randomized placebo controlled pilot trial (CANTREAT study).","volume":"40","author":"Albert","year":"2014","journal-title":"Intensive Care Med"},{"key":"R121-20230823","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","article-title":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.","volume":"166","author":"Hotchkiss","year":"2001","journal-title":"J Immunol"},{"key":"R122-20230823","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure.","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"R123-20230823","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/cc13980","article-title":"Early adaptive immune suppression in children with septic shock: a prospective observational study.","volume":"18","author":"Muszynski","year":"2014","journal-title":"Crit Care"},{"key":"R124-20230823","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/cc12711","article-title":"Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis.","volume":"17","author":"Chang","year":"2013","journal-title":"Crit Care"},{"key":"R125-20230823","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SHK.0000000000000317","article-title":"Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.","volume":"43","author":"Shindo","year":"2015","journal-title":"Shock"},{"key":"R126-20230823","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1615\/CritRevImmunol.2014009988","article-title":"Mechanism of activation-induced cell death of T cells and regulation of FasL expression.","volume":"34","author":"Arakaki","year":"2014","journal-title":"Crit Rev Immunol"},{"key":"R127-20230823","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2174\/092986708784872384","article-title":"Storage, expression and function of Fas ligand, the key death factor of immune cells.","volume":"15","author":"Lettau","year":"2008","journal-title":"Curr Med Chem"},{"key":"R128-20230823","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1359-6101(02)00072-2","article-title":"Non-apoptotic Fas signaling.","volume":"14","author":"Wajant","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"R129-20230823","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12016-015-8466-y","article-title":"Updated understanding of autoimmune lymphoproliferative syndrome (ALPS).","volume":"50","author":"Li","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"R130-20230823","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nm0497-409","article-title":"Essential roles of the Fas ligand in the development of hepatitis.","volume":"3","author":"Kondo","year":"1997","journal-title":"Nat Med"},{"key":"R131-20230823","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1164\/ajrccm.161.1.9810007","article-title":"Upregulation of two death pathways of perforin\/granzyme and FasL\/Fas in septic acute respiratory distress syndrome.","volume":"161","author":"Hashimoto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R132-20230823","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.4049\/jimmunol.163.4.2217","article-title":"Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS).","volume":"163","author":"Matute-Bello","year":"1999","journal-title":"J Immunol"},{"key":"R133-20230823","doi-asserted-by":"crossref","first-page":"G354","DOI":"10.1152\/ajpgi.2000.278.3.G354","article-title":"Fas and Fas ligand in gut and liver.","volume":"278","author":"Pinkoski","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R134-20230823","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.leukres.2011.08.005","article-title":"Elevated Fas\/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: A clinical analysis.","volume":"36","author":"Wu","year":"2012","journal-title":"Leuk Res"},{"key":"R135-20230823","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/cc9965","article-title":"Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis.","volume":"15","author":"Paunel-G\u00f6rg\u00fcl\u00fc","year":"2011","journal-title":"Crit Care"},{"key":"R136-20230823","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<21::AID-AJH5>3.0.CO;2-8","article-title":"Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation.","volume":"61","author":"Hori","year":"1999","journal-title":"Am J Hematol"},{"key":"R137-20230823","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0305-4179(03)00201-8","article-title":"Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burns.","volume":"29","author":"Yamada","year":"2003","journal-title":"Burns"},{"key":"R138-20230823","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<116::AID-AJH8>3.0.CO;2-8","article-title":"Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromes.","volume":"64","author":"Emmenegger","year":"2000","journal-title":"Am J Hematol"},{"key":"R139-20230823","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428190109097673","article-title":"Interleukin-18 in hemophagocytic lymphohistiocytosis.","volume":"42","author":"Takada","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"R140-20230823","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yexcr.2014.03.014","article-title":"Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity.","volume":"325","author":"Meeths","year":"2014","journal-title":"Exp Cell Res"},{"key":"R141-20230823","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cytogfr.2014.10.001","article-title":"Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders.","volume":"26","author":"Brisse","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"R142-20230823","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","article-title":"Hemophagocytic syndromes\u2013an update.","volume":"28","author":"Janka","year":"2014","journal-title":"Blood Rev"},{"key":"R143-20230823","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjh.12293","article-title":"Advances in understanding the pathogenesis of HLH.","volume":"161","author":"Usmani","year":"2013","journal-title":"Br J Haematol"},{"key":"R144-20230823","first-page":"1414","article-title":"Haemophagocytic syndrome in rheumatic patients. A systematic review.","volume":"16","author":"Atteritano","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R145-20230823","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1182\/blood-2013-04-495309","article-title":"Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.","volume":"121","author":"Terrell","year":"2013","journal-title":"Blood"},{"key":"R146-20230823","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2249.2003.02237.x","article-title":"Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis.","volume":"133","author":"Takada","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"R147-20230823","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"key":"R148-20230823","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/art.38793","article-title":"Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.","volume":"66","author":"Kaufman","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R149-20230823","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R150-20230823","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu Rev Med"},{"key":"R151-20230823","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/TP.0000000000000845","article-title":"Risk-adapted treatment for severe B-lineage posttransplant lymphoproliferative disease after solid organ transplantation in children.","volume":"100","author":"Giraldi","year":"2016","journal-title":"Transplantation"},{"key":"R152-20230823","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1097\/01.CCM.0000227659.14644.3E","article-title":"Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange.","volume":"34","author":"Darmon","year":"2006","journal-title":"Crit Care Med"},{"key":"R153-20230823","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/00003246-200207000-00015","article-title":"Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma.","volume":"30","author":"Nakos","year":"2002","journal-title":"Crit Care Med"},{"key":"R154-20230823","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":"Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: Results of a prospective multicenter phase 2 study.","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood"},{"key":"R155-20230823","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/j.1600-6143.2012.04206.x","article-title":"Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): A Children\u2019s Oncology Group Report.","volume":"12","author":"Gross","year":"2012","journal-title":"Am J Transplant"},{"key":"R156-20230823","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"key":"R157-20230823","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: Reanalysis of a prior phase III trial.","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"R158-20230823","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/CCM.0000000000002053","article-title":"Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia.","volume":"45","author":"Fitzgerald","year":"2017","journal-title":"Crit Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201703001-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T22:16:26Z","timestamp":1750025786000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201703001-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":158,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000001052","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}